Joseph Cappello - VP, Pharmaceutical Development at GENELUX Corp

Insider Transactions and Holdings

Entity Type
Individual
Role
VP, Pharmaceutical Development
Stock Symbol
GNLX on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Joseph Cappello since 10/5/2023

Holdings reported by Joseph Cappello for GENELUX Corp

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 21K $44.4K $2.12 Mar 14, 2024 Direct
Stock Option (right to buy) 65K Sep 11, 2023 Direct Common Stock

Transactions reported by Joseph Cappello for GENELUX Corp

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.